4d hails ‘significant step forward’ in research update
MEDICAL research company 4d Pharma has given a second positive research update in three days.
Since floating on AIM last year, shares in the Manchester company have defied a sometimes turbulent stock market to more than double to 435p. The stock rose again in early trading to 464.5p, up nearly 7%.
4d's latest news focuses on the MicroRx Platform which is developing new live bacteria to create bioterapeutics to treat inflammatory and auto-immune diseases.
It began working on MicroRX in May 2014, an... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...